查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1974266

經腸營養市場：依產品類型、劑型、年齡層及最終用戶分類－2026-2032年全球預測

Enteral Feedings Market by Product Type, Form, Age Group, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，經腸營養市場價值將達到 23.1 億美元，到 2026 年將成長至 24.5 億美元，到 2032 年將達到 40.1 億美元，複合年成長率為 8.17%。

主要市場統計數據
基準年 2025 23.1億美元
預計年份：2026年 24.5億美元
預測年份 2032 40.1億美元
複合年成長率 (%) 8.17%

從策略觀點看經腸營養趨勢，有助於醫療保健決策者明確臨床需求、供應鏈複雜性和相關人員的優先事項。

經腸營養已從專門的臨床干預發展成為一個涵蓋急性期護理、長期支持和家庭營養管理的跨學科領域。臨床團隊、採購經理、產品開發人員和支付方在諸如給藥安全性、配方精準性、非專業人員易用性以及符合不斷變化的監管要求等通用優先事項上開展了越來越多的合作。因此，經腸營養現在需要製定兼顧臨床療效、營運靈活性和患者體驗的策略。

從急性照護到社區醫療保健，重塑經腸營養的實踐和產品創新：技術、法規和護理服務模式的新趨勢。

在經腸營養領域，技術、照護模式和監管方面正發生著融合性的變革，重新定義了產品的研發、採購和部署方式。泵浦的精確度、連接性和安全聯鎖等方面的技術進步減少了人為錯誤，並實現了遠端監測；而配方科學則提供了更個人化的營養方案，以滿足不同病患小組的代謝需求。因此，各相關人員需要重新思考如何將產品規格與臨床工作流程結合，以實現臨床價值和營運效率的雙重提升。

評估美國在 2025 年實施的關稅措施對籌資策略、價格透明度和臨床採購慣例的累積影響。

美國2025年實施的關稅措施，為經腸營養產品和製劑的採購及採購決策增添了新的複雜性。採購團隊和製造商正在重新評估供應商所在地，重新談判契約，並調整庫存政策，以應對成本結構和物流計劃的變化，同時降低跨境關稅和海關程序波動帶來的風險。這些調整正在重塑採購方法和供應商選擇標準。

基於最終用戶、產品、形式和年齡層的差異，對產品設計、通路策略和臨床引入進行詳細細分的影響。

市場區隔為產品設計和市場規劃與臨床工作流程和使用者需求的匹配提供了一個切實可行的觀點。觀察最終用戶的差異可以發現，診所、居家照護機構、醫院（分為普通病房和加護病房）以及長期護理機構對供應系統、看護者培訓和包裝形式都有不同的要求。例如，在重症監護環境中，準確性和與監測系統的整合是優先考慮的因素，而在居家照護中，便攜性、易用性和針對非醫療專業人員的看護者指導則更為重要。

區域需求因素和政策趨勢（北美和南美、歐洲、中東和非洲以及亞太地區）影響分銷、監管和臨床實踐。

區域趨勢影響著監管預期、報銷環境和分銷物流，進而決定經腸營養產品的普及速度。在美洲，監管機構和大規模綜合醫療保健系統正在推動連接器和標籤規則的標準化，而採購聯盟則對供應商選擇和合約條款施加重大影響。這為那些能夠證明其產品除了臨床療效外還能帶來成本節約的營運效益的製造商創造了機會。

主要製造商和經銷商的競爭定位和策略舉措決定了產品系列、夥伴關係模式和市場進入通路。

經腸營養領域的競爭格局由差異化的產品系列、策略聯盟以及跨市場品管系統的擴展能力所塑造。主要企業正從營養製劑拓展至整合輸送系統，將幫浦、管路和連接裝置結合，打造加值提案，進而提升臨床安全性和管理透明度。這種設備和製劑能力的融合提高了新進入者的准入門檻，並凸顯了臨床證據、設備相容性和服務模式的重要性。

為產業領導者提供的實用策略建議：調整研發、商業模式和供應鏈韌性，以適應不斷變化的臨床和法規環境。

產業領導者應優先採取一系列切實可行的措施，使其商業策略與不斷變化的臨床需求和營運實際情況相適應。首先，投資於模組化產品架構，以便針對不同的醫療環境和病患群體快速進行配置變更。這種方法可以縮短產品變體的上市時間，同時簡化監理申報流程。其次，透過採購多元化、在適當情況下採用近岸外包以及與貿易夥伴分擔關稅和物流風險的合約機制，增強供應鏈的韌性。這些措施可以提高供應的連續性，並降低單點故障的風險。

採用透明的調查方法，明確指出用於解釋臨床趨勢、採購行為和產品創新的資料來源、定性訪談和分析框架。

本研究結合了質性訪談、文獻回顧和有針對性的二手資料分析，以三角驗證證據並從中得出可操作的見解。關鍵要素包括與急診、長期照護和居家醫療機構的臨床醫生，以及綜合醫療保健系統的採購經理和產品開發主管進行結構化對話。這些訪談用於檢驗觀察結果，並了解真實環境中的決策標準。二手資料的選擇並非基於單一資訊來源，而是為了提供有關監管指南、臨床實踐標準和技術趨勢的背景資訊。

這是一份權威的綜合分析報告，重點介紹了對臨床醫生、採購團隊和行業高管至關重要的見解，旨在幫助他們了解經腸營養。

總之，經腸營養正處於轉折點。在這個臨床預期、供應鏈現實和監管要求交會的關鍵時刻，整合實證策略將帶來成效。能夠平衡產品創新與嚴格運作（尤其是在來源多元化、臨床證據累積和數位化整合方面）的製造商和醫療系統領導者，將更有能力滿足加護病房、普通病房、長期照護機構和家庭護理中複雜的營養需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章經腸營養市場：依產品類型分類

  • Bolus營養
  • 持續營養
  • 間歇性營養補充

第9章經腸營養市場：依形式分類

  • 液體
    • 濃縮型
    • 即用型
  • 粉末

第10章經腸營養市場：依年齡層別分類

  • 成人版
  • 老年人
  • 兒童

第11章經腸營養市場：依最終用戶分類

  • 診所
  • 居家照護
  • 醫院
    • 普通病房
    • 加護病房
  • 長期照護機構

第12章經腸營養市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章經腸營養市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章經腸營養市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國經腸營養市場

第16章：中國經腸營養市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Amsino International Inc
  • Applied Medical Technology Inc
  • Avanos Medical Inc
  • B. Braun Melsungen AG
  • Baxter International Inc
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health Inc
  • CONMED Corporation
  • Cook Medical LLC
  • Danone SA
  • Fresenius SE & Co. KGaA
  • Glanbia Plc
  • Global Health Products Inc
  • Hormel Foods Corporation
  • ICU Medical Inc
  • Kimberly-Clark Corporation
  • Medline Industries LP
  • Meiji Holdings Co., Ltd.
  • Moog Inc
  • Nestle SA
  • Perrigo Company PLC
  • Reckitt Benckiser Group PLC
  • Vygon SA
Product Code: MRR-3F575F196088

The Enteral Feedings Market was valued at USD 2.31 billion in 2025 and is projected to grow to USD 2.45 billion in 2026, with a CAGR of 8.17%, reaching USD 4.01 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.31 billion
Estimated Year [2026] USD 2.45 billion
Forecast Year [2032] USD 4.01 billion
CAGR (%) 8.17%

A strategic orientation to enteral feeding dynamics that frames clinical demand, supply chain complexity, and stakeholder priorities for healthcare decision-makers

Enteral feeding has evolved from a specialized clinical intervention to a multidisciplinary field spanning acute care, long-term support, and home-based nutrition management. Clinical teams, procurement leads, product developers, and payers increasingly converge around shared priorities: safety of administration, formulation precision, ease of use for non-specialists, and adherence to evolving regulatory expectations. Consequently, enteral feeding now demands strategies that balance clinical efficacy with operational resilience and patient experience.

This introduction frames the principal forces shaping contemporary enteral nutrition. The narrative begins with clinical imperatives in intensive care and chronic care environments, then moves to the operational drivers in hospitals and home care settings that influence procurement and product selection. Finally, it profiles the cross-cutting themes-connectivity and digital workflows, supply chain continuity, and sustainability-that are central to strategic decision-making. By establishing this orientation, the reader gains a concise but comprehensive backdrop for subsequent sections that analyze transformational shifts, policy effects, segmentation dynamics, regional considerations, competitive behaviors, and recommended actions for stakeholders.

Emerging technological, regulatory and care-delivery shifts reshaping enteral nutrition practice and product innovation across acute and community care settings

The enteral feeding landscape is experiencing convergent shifts in technology, care delivery models, and regulatory scrutiny that are redefining how products are developed, procured, and deployed. Technological advances in pump accuracy, connectivity, and safety interlocks are reducing human error and enabling remote monitoring, while formulation science is delivering more tailored nutrient profiles to address metabolic needs across patient groups. As a result, stakeholders must rethink product specifications and integration with clinical workflows to capture both clinical value and operational efficiencies.

Concurrently, care delivery is decentralizing; greater emphasis on home care and early hospital discharge has elevated the importance of usability, packaging formats, and caregiver training. This transition is accompanied by intensified regulatory attention to labeling, traceability, and device-feeding system compatibility, prompting manufacturers to invest in compliance and post-market surveillance. Together, these dynamics favor companies that can align robust clinical evidence with modular product portfolios and agile supply chains, enabling faster adoption in settings ranging from intensive care units to community-based clinics.

Assessing the cumulative consequences of recent United States tariff measures introduced in 2025 on sourcing strategies, pricing transparency, and clinical procurement practices

The tariff measures introduced by the United States in 2025 have introduced a new layer of complexity into procurement and sourcing decisions for enteral feeding supplies and formulations. Procurement teams and manufacturers are responding to altered cost structures and logistical timelines by re-evaluating supplier footprints, renegotiating contracts, and recalibrating inventory policies to mitigate exposure to cross-border duties and customs variability. In turn, these adaptations are reshaping procurement playbooks and vendor selection criteria.

Operationally, the tariff environment has accelerated interest in supply diversification and nearshoring strategies. Many organizations are assessing dual-sourcing models that reduce single-vendor dependence while preserving access to specialty inputs such as nutrient concentrates and packaging substrates. In parallel, purchasing groups and hospital systems are placing greater emphasis on contract clauses that address tariff pass-throughs, lead-time guarantees, and dispute resolution. Taken together, these shifts underscore the strategic premium on supply chain agility and commercial arrangements that can absorb or deflect the operational impacts of tariff policy changes.

Granular segmentation-driven implications for product design, channel strategy, and clinical adoption informed by end user, product, form, and age group distinctions

Segmentation offers a practical lens to align product design and go-to-market plans with clinical workflows and user needs. When observed through end user distinctions, clinics, home care environments, hospitals-subdivided into general wards and intensive care units-and long term care facilities each impose distinct requirements on delivery systems, caregiver training, and packaging formats. For example, intensive care settings prioritize precision and integration with monitoring systems, whereas home care emphasizes portability, simplicity, and caregiver instructions tailored for non-clinician use.

Product type further refines value propositions across bolus feeding, continuous feeding, and intermittent feeding, each demanding unique pump features, tubing sets, and formulation stability profiles. Form considerations likewise influence logistics and user preference: products available as liquid and powder present trade-offs between immediate readiness and transport efficiency, and the liquid category in particular divides into concentrate and ready-to-use options that change clinical workflow and storage needs. Age group segmentation spanning adult, geriatric, and pediatric cohorts requires tailored nutrient profiles, administration devices, and labeling to ensure safety and adherence. Synthesizing these dimensions helps manufacturers prioritize SKU rationalization, devise targeted clinical education, and optimize channel strategies for distinct care environments.

Regional demand drivers and policy vectors across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence distribution, regulation, and clinical practice

Regional dynamics shape regulatory expectations, reimbursement environments, and distribution logistics, which in turn determine the cadence of adoption for enteral feeding products. Across the Americas, regulatory authorities and large integrated health systems often drive standardization of connectors and labeling conventions, while procurement consortia exert notable influence on supplier selection and contract terms. This creates opportunities for manufacturers who can demonstrate operational savings alongside clinical outcomes.

In Europe, Middle East & Africa, heterogeneity in regulatory pathways and health system architectures requires adaptable market entry strategies and tiered product offerings. Manufacturers must navigate divergent national standards and reimbursement models, and they benefit from localized clinical evidence generation to support adoption. Asia-Pacific markets are characterized by rapid uptake of home care services and investment in domestic production capabilities; this region's emphasis on local manufacturing and strategic partnerships makes it vital for companies to balance global product consistency with regional customization. Across all regions, attention to logistics resilience, regulatory alignment, and culturally appropriate patient and caregiver education remains essential for sustained market access and clinical uptake.

Competitive positioning and strategic moves by leading manufacturers and distributors that determine product portfolios, partnership models, and routes to market

Competitive dynamics in the enteral feeding space are shaped by differentiated portfolios, strategic partnerships, and the ability to scale quality systems across markets. Leading players are extending beyond nutrition formulations into integrated delivery systems, combining pumps, tubing, and connectivity features to create bundled value propositions that address clinical safety and administrative transparency. This convergence of device and formulation capabilities raises the bar for newcomers and underscores the importance of clinical evidence, device compatibility, and service models.

Market leaders are also investing in specialized formulations and supply chain certification to meet stringent clinical and regulatory requirements. In parallel, a cohort of agile manufacturers and regional distributors is capitalizing on niche opportunities-such as pediatric-specific formulations, geriatric-friendly packaging, or low-resource setting solutions-by offering tailored products and localized support. Strategic alliances with clinical institutions, technology vendors, and logistics partners are increasingly important for scaling post-market surveillance, training programs, and digital tools that improve adherence and outcomes. Ultimately, competitive advantage accrues to organizations that integrate product excellence with demonstrable operational support and evidence-based clinical engagement.

Practical strategic recommendations for industry leaders to align R&D, commercial models, and supply chain resilience with evolving clinical and regulatory realities

Industry leaders should prioritize a set of pragmatic actions to align commercial strategy with evolving clinical needs and operational realities. First, invest in modular product architectures that allow rapid configuration for different care settings and patient cohorts; this approach reduces time to market for variants while simplifying regulatory submissions. Second, strengthen supply chain resilience through diversified sourcing, nearshoring where appropriate, and contractual mechanisms that share tariff and logistics risk with trading partners. These measures enhance continuity of supply and reduce exposure to single-point failures.

Third, build clinical evidence programs that extend beyond controlled trials to include real-world data from home care and long term care settings; this will support payer conversations and clinical adoption. Fourth, embed connectivity and usability into product development, ensuring that devices and formulations integrate with electronic health records and remote monitoring platforms. Finally, develop targeted commercial models that reflect regional reimbursement practices and stakeholder incentives, and complement them with robust training and post-market support to drive adoption and ensure safe administration.

Transparent methodology outlining data sources, qualitative interviews, and analytical frameworks used to interpret clinical trends, procurement behaviors, and product innovation

The research approach combined qualitative interviews, document review, and targeted secondary analysis to triangulate evidence and surface actionable insights. Primary engagements included structured conversations with clinicians across acute, long term, and home care settings, procurement leaders from integrated health systems, and product development executives; these interviews were used to corroborate observational findings and understand decision criteria in real-world settings. Secondary sources were selected to provide context on regulatory guidance, clinical practice standards, and technology trends without relying on single-source narratives.

Analytical frameworks applied in the study included value-chain mapping to identify supply risks, stakeholder journey analysis to highlight pain points in administration and procurement, and capability benchmarking to assess supplier readiness across quality systems and evidence generation. Throughout the process, iterative validation workshops were held with subject-matter experts to refine interpretations and ensure that conclusions reflected operational realities. Transparency around limitations and assumptions was maintained, and appendices document interview protocols, inclusion criteria, and the audit trail for qualitative coding.

Conclusive synthesis highlighting priority implications for clinicians, procurement teams, and industry executives seeking to navigate the enteral feeding landscape

In conclusion, enteral feeding is at an inflection point where clinical expectations, supply chain realities, and regulatory demands converge to reward integrated, evidence-driven strategies. Manufacturers and health system leaders that couple product innovation with operational rigor-especially in supply diversification, clinical evidence generation, and digital integration-will be better positioned to meet the complex needs of intensive care, general wards, long term care, and home-based administration.

Moving forward, stakeholders should treat adaptability as a core organizational capability: whether responding to policy changes that affect cross-border trade or tailoring formulations and delivery systems to distinct patient populations, the most resilient organizations will be those that translate insights into pragmatic actions across R&D, procurement, and clinical engagement. By doing so, they can improve safety, enhance patient experience, and sustain commercial performance in a market that increasingly prizes interoperability, traceability, and demonstrable clinical value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Enteral Feedings Market, by Product Type

  • 8.1. Bolus Feeding
  • 8.2. Continuous Feeding
  • 8.3. Intermittent Feeding

9. Enteral Feedings Market, by Form

  • 9.1. Liquid
    • 9.1.1. Concentrate
    • 9.1.2. Ready To Use
  • 9.2. Powder

10. Enteral Feedings Market, by Age Group

  • 10.1. Adult
  • 10.2. Geriatric
  • 10.3. Pediatric

11. Enteral Feedings Market, by End User

  • 11.1. Clinics
  • 11.2. Home Care
  • 11.3. Hospitals
    • 11.3.1. General Wards
    • 11.3.2. Intensive Care Units
  • 11.4. Long Term Care Facilities

12. Enteral Feedings Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Enteral Feedings Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Enteral Feedings Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Enteral Feedings Market

16. China Enteral Feedings Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Amsino International Inc
  • 17.7. Applied Medical Technology Inc
  • 17.8. Avanos Medical Inc
  • 17.9. B. Braun Melsungen AG
  • 17.10. Baxter International Inc
  • 17.11. Becton Dickinson and Company
  • 17.12. Boston Scientific Corporation
  • 17.13. Cardinal Health Inc
  • 17.14. CONMED Corporation
  • 17.15. Cook Medical LLC
  • 17.16. Danone S.A.
  • 17.17. Fresenius SE & Co. KGaA
  • 17.18. Glanbia Plc
  • 17.19. Global Health Products Inc
  • 17.20. Hormel Foods Corporation
  • 17.21. ICU Medical Inc
  • 17.22. Kimberly-Clark Corporation
  • 17.23. Medline Industries LP
  • 17.24. Meiji Holdings Co., Ltd.
  • 17.25. Moog Inc
  • 17.26. Nestle S.A.
  • 17.27. Perrigo Company PLC
  • 17.28. Reckitt Benckiser Group PLC
  • 17.29. Vygon S.A.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENTERAL FEEDINGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENTERAL FEEDINGS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENTERAL FEEDINGS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ENTERAL FEEDINGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ENTERAL FEEDINGS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENTERAL FEEDINGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY BOLUS FEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY BOLUS FEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY BOLUS FEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY CONTINUOUS FEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY CONTINUOUS FEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY CONTINUOUS FEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY INTERMITTENT FEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY INTERMITTENT FEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY INTERMITTENT FEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY CONCENTRATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY CONCENTRATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY CONCENTRATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY READY TO USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY READY TO USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY READY TO USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY GENERAL WARDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY GENERAL WARDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY GENERAL WARDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY INTENSIVE CARE UNITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY INTENSIVE CARE UNITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY INTENSIVE CARE UNITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY LONG TERM CARE FACILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY LONG TERM CARE FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY LONG TERM CARE FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS ENTERAL FEEDINGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ENTERAL FEEDINGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. AFRICA ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. ASEAN ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. ASEAN ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. ASEAN ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 121. GCC ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GCC ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. GCC ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 124. GCC ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 125. GCC ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GCC ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. GCC ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPEAN UNION ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPEAN UNION ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPEAN UNION ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. BRICS ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 142. G7 ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. G7 ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. G7 ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 145. G7 ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 146. G7 ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. G7 ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. G7 ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 149. NATO ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. NATO ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. NATO ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 152. NATO ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 153. NATO ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. NATO ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. NATO ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES ENTERAL FEEDINGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA ENTERAL FEEDINGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 165. CHINA ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. CHINA ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 168. CHINA ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. CHINA ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)